flipper44,
About 7 arrows all pointed at one target and released to hit it at about the same time. July, August and boom! HE (typically Feb or Sept announcements), PIM part 2 (waiting on manufacturing readiness including patent approvals?), Direct Phase 2 (waiting on possible final combo agreement) , combo trials (DCVax-L and or Direct), worldwide manufacturing expansion inspection and equivalency approvals, internal investigation report, external investigation report.
Lack of accrual at this point essentially equals validation that the company and FDA and other regulators must figure out.